The University of Southampton
Medicine
Phone:
(023) 8059 1767
Email:
K.Harman@soton.ac.uk

Dr Kim Harman DHealth, MSc, BSc(hons)

Trial Manager

Dr Kim Harman's photo
Related links
Personal homepage

Kim is working as a trial manager for two trials both aimed at helping reduce the use of antibiotics. Her clinical background working in infections helps both understand the need for this and the tensions of working as a clinician and researcher.

My clinical background helps me ensure we are undertaking research that will make a noticeable difference to real people’s lives. I have a particular interest in infection and alternative ways of either reducing antibiotic consumption or making sure they are used appropriately.

Kim is a clinician by background having trained as a Podiatrist and worked >25 years as a senior clinician most recently being the Lead Podiatrist for Diabetes in the Bath clinical catchment area. As a research project manager she shows -

Personal effectiveness; she is a very confident, capable, organiser and co-ordinator of teams and supports and motivates staff. She is disciplined, motivated and thorough but can recognize her boundaries.

Communication / influencing skills; She has good advocacy skills for individuals with empathy; can communicate ideas clearly in a style appropriate to purpose. Providing, by leading by example, support and mentorship to promote life-long learning for busy professionals.

Networking and teamworking; She is a good facilitator with good negotiation skills able to co-ordinate different groups. Working well within a team environment recognising the contributions others bring.

Research / project management; She has the ability to set her own goals and can prioritise activities, acquiring and collating relevant information, and using time efficiently through planning.

Research environment; She is well able to appreciate the standards of good research and understand the issues and rights of researchers and research subjects.

Research skills and techniques; She has the ability to recognise problems and use critical thinking and appraisal skills to develop ideas which can be documented, reflected on and further developed. She has developed the skills required for scientific writing. Kim has worked within the Freedom of Information Act to protect Intellectual Property developed by research projects and has costed projects ‘from scratch’ being aware of the funding requirements and regulations of different funding bodies.

Career management; She appreciates the need for and show commitment to continued professional development with an insight into the nature of skills being transferable between environments. She is passionate about life-long learning for all staff.

BSc(hons) University of Brighton (1987), MSc University of the West of England (2004), DHealth University of Bath (2010)

DUTY study manager (University of Bristol 2012),

Bristol Infection Projects’ Manager (University of Bristol 2012-2015)

Research

Responsibilities

Publications

Contact

Research interests

RUTI website

The aim of the RUTI trial is to conduct a 16 week feasibility study of 80 women with Recurrent UTIs aged between 18-65 years comparing standardised Chinese herbal treatment versus placebo, delivered by GP practice nurses, with individualised herbal treatment versus placebo delivered by CHM practitioners.

As both GP and CHM practitioner options will provide verum (active herbal preparations) and placebo treatments there will be 4 arms to this trial:

1. Active standardised CHM treatment delivered via GPs (n=20)

2. Placebo standardised CHM treatment delivered via GPs (n=20)

3. Active individualised treatment delivered via CHM practitioners (n=20)

4. Placebo individualised treatment delivered via CHM practitioners (n=20)

Analysis of these 4 groups should provide preliminary data on:

A. the effect size of individualised, standardised and placebo treatments in reducing the frequency and severity of recurrent UTIs.

B. on the feasibility of administering CHM via GP practices and via non-NHS CHM practitioner and, using the therapeutic environment in eliciting contextual treatment effects in the delivery of CHM.

These data are important for future research into herbal medicines.

 

ARTIC PC

This will be an RCT of antibiotic and placebo nested within an observational study. We are looking to investigate the usefulness of antibiotics in this age group, it follows a European wide trial that was very similar for adults. Children will be provided antibiotic or placebo and keep a symptom diary for up to 28 days. They can opt to provide a throat swab, a blood sample and have a chest x-ray.

Design: RCT nested in an observational study.

Intervention: 7 days of tds amoxicillin or placebo for those in the RCT

The aim: To provide evidence to inform the management of chest infections in children.

The objectives are:

• To estimate the effectiveness of amoxicillin overall and in key clinical subgroups of children presenting with uncomplicated (non-pneumonic) lower respiratory tract infection in primary care.

• To estimate the cost-effectiveness of antibiotics overall and in key clinical subgroups of children presenting with uncomplicated lower respiratory tract infection in primary care.

• To explore the estimates of effectiveness according to key pathophysiological subgroups (the presence of bacterial pathogens; raised C reactive protein measurement or white cell count; the presence of clinically undetected consolidation on X ray; pulse oximetry; lung function).

 


Research group

Primary Care & Population Sciences Academic Units

Research project(s)

RUTI

This trial is a multi-centred, pragmatic, double blinded randomised controlled feasibility study involving 4 groups of 20 women (given a 20% drop out this will require the recruitment of 96 women). There is a post trial follow up at 6 months.

ARTIC PC

We are looking to investigate the usefulness of antibiotics in this age group, it follows a European wide trial that was very similar for adults. Children will be provided antibiotic or placebo and keep a symptom diary for up to 28 days. They can opt to provide a throat swab, a blood sample and have a chest x-ray.

RUTI

Kim is responsible for the running of the RUTI trial. This means discussing the contracts required with the NHS laboratories to provide blood sample processing and liaison with the CRN for site selection and training. Kim will be responsible for updating the Ethics committee of the progress of the trial and any amendments made, with additionally ensuring Research assurance is in place. Kim will monitor recruitment for both safety and numbers.

 

ARTIC

Kim is responsible for the running of the ARTIC PC study and trial. This means discussing the contracts required with x ray departments, an NHS laboratory to provide blood sample processing, another NHS laboratory to process throat swabs and liaison with the CRN for site selection and training. Kim will be responsible for updating the MHRA and Ethics committee of the progress of the study and trial and any amendments made, with additionally ensuring Research assurance is in place. Kim will monitor recruitment for both safety and numbers. The project is being run as a pilot in Autumn/Winter 2016/17 around Southampton extending to include Oxford, Cardiff and Bristol in 2017/18 and 2018/19.

Articles

Report

Dr Kim Harman
Primary Care and Population Sciences
Faculty of Medicine
University of Southampton
Aldermoor Health Centre
Aldermoor Close
Southampton
SO16 5ST

Room Number:9590 AHC/118/S2

Telephone:(023) 8059 1767
Email:K.Harman@soton.ac.uk

Share this profile Facebook Google+ Twitter Weibo

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×